John M. Esdaile

Q: What Schools Are Affiliated With John M. Esdaile

John M. Esdaile is affiliated with the following schools: University of Calgary, McGill University, University of British Columbia

John M. Esdaile's AcademicInfluence.com Rankings

John M. Esdaile

Philosophy

#7741

World Rank

#10992

Historical Rank

Logic

#4778

World Rank

#6107

Historical Rank

philosophy Degrees

Download Badge

Philosophy

John M. Esdaile's Degrees

Doctorate Medicine University of British Columbia

Why Is John M. Esdaile Influential?

(Suggest an Edit or Addition)

(See a Problem?)

John M. Esdaile's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. (1999) (1841)
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. (2008) (1306)
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. (2001) (1183)
Adult Still's Disease: Manifestations, Disease Course, and Outcome in 62 Patients (1991) (671)
A Population‐Based, Randomized Clinical Trial on Back Pain Management (1997) (492)
A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. (2005) (403)
The Quebec Back Pain Disability Scale: Measurement Properties (1995) (369)
Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. (1999) (279)
Sexual and physical abuse in women with fibromyalgia syndrome. (1995) (258)
The Quebec Back Pain Disability Scale: conceptualization and development. (1996) (237)
Low-dose cyclosporin versus placebo in patients with rheumatoid arthritis (1990) (235)
Gaps in care for rheumatoid arthritis: a population study. (2005) (225)
Indications for total hip and total knee arthroplasties. Results of orthopaedic surveys. (1996) (224)
Measurement of systemic lupus erythematosus activity in clinical research. (1988) (212)
Time-Dependent Hazard Ratio: Modeling and Hypothesis Testing with Application in Lupus Nephritis (1996) (195)
Reliability of the knee examination in osteoarthritis: effect of standardization. (2004) (188)
Functional disability scales for back pain. (1995) (186)
Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. (1996) (186)
Predictors of Back Pain in a General Population Cohort (2004) (185)
Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. (2000) (183)
The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. (1989) (182)
A controlled two-centre trial of parenteral methotrexate therapy for refractory rheumatoid arthritis. (1984) (181)
Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis. (2008) (176)
Alternative medicine use in fibromyalgia syndrome. (1996) (171)
Bias in case-control studies. A review. (1990) (170)
Viscosupplementation: Therapeutic Mechanisms and Clinical Potential in Osteoarthritis of the Knee (2000) (159)
Practical pharmacogenetics: the cost effectiveness of screening for thiopurine s-methyltransferase polymorphisms in patients with rheumatological conditions treated with azathioprine. (2002) (154)
Reactive fibromyalgia syndrome. (1992) (152)
The benefit of early treatment with immunosuppressive agents in lupus nephritis. (1994) (151)
Rheumatic diseases in North America's indigenous peoples. (1999) (150)
A Controlled Study of Diffuse Idiopathic Skeletal Hyperostosis Clinical Features and Functional Status (1997) (147)
Classification systems in orthopaedics. (2002) (146)
Adult Still's disease. (1980) (144)
Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. (1997) (140)
Randomized, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. (2004) (139)
Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. (2009) (138)
Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. (2013) (137)
Low-dose methotrexate with leucovorin (folinic acid) in the management of rheumatoid arthritis. Results of a multicenter randomized, double-blind, placebo-controlled trial. (1993) (136)
The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. (2004) (135)
Systemic lupus erythematosus in North American Indians: a population based study. (2000) (135)
The randomized clinical trial in orthopaedics: obligation or option? (1986) (134)
Management of occupational back pain: the Sherbrooke model. Results of a pilot and feasibility study. (1994) (133)
A long-term study of hydroxychloroquine withdrawal on exacerbations in systemic lupus erythematosus. The Canadian Hydroxychloroquine Study Group. (1998) (132)
A Comparison of Four Indirect Methods of Assessing Utility Values in Rheumatoid Arthritis (2004) (128)
Reliability of Tuberculin Skin Test Measurement (1997) (125)
Psychosocial contributors to mental and physical health in patients with systemic lupus erythematosus. (1998) (125)
Randomized discontinuation trials: utility and efficiency. (1993) (114)
Identification of modifiable work-related factors that influence the risk of work disability in rheumatoid arthritis. (2004) (114)
A 48-week, randomized, double-blind, double-observer, placebo-controlled multicenter trial of combination methotrexate and intramuscular gold therapy in rheumatoid arthritis: results of the METGO study. (2005) (113)
Not all "quality-adjusted life years" are equal. (2007) (112)
Recent corticosteroid use and recent disease activity: independent determinants of coronary heart disease risk factors in systemic lupus erythematosus? (2008) (110)
Minimal clinically important difference for 7 measures of fatigue in patients with systemic lupus erythematosus. (2008) (103)
Back school in a first episode of compensated acute low back pain: a clinical trial to assess efficacy and prevent relapse. (1996) (102)
Posterior reversible encephalopathy syndrome--an underrecognized manifestation of systemic lupus erythematosus. (2006) (101)
An experiment in reducing interobserver variability of the examination for joint tenderness. (1988) (101)
Medication Nonadherence in Systemic Lupus Erythematosus: A Systematic Review (2017) (99)
Mortality in ANCA-associated vasculitis: ameta-analysis of observational studies (2017) (98)
A clinical study of older age rheumatoid arthritis with comparison to a younger onset group. (1983) (93)
Are indirect utility measures reliable and responsive in rheumatoid arthritis patients? (2005) (91)
The pathogenesis and prognosis of lupus nephritis: information from repeat renal biopsy. (1993) (89)
A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. (1993) (89)
The time-dependence of long-term prediction in lupus nephritis. (1994) (88)
Determination of the minimal clinically important difference for seven fatigue measures in rheumatoid arthritis. (2008) (87)
The association of soft-tissue rheumatism and hypermobility. (1998) (86)
Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population‐Based Study (2017) (85)
Routine immunologic tests in systemic lupus erythematosus: is there a need for more studies? (1996) (85)
Discontinuation of antimalarial drugs in systemic lupus erythematosus. (1999) (84)
Cardiovascular risk factor screening in systemic lupus erythematosus. (2003) (83)
Antiphospholipid antibodies in systemic lupus erythematosus: evidence of an association with positive Coombs' and hypocomplementemia. (1988) (83)
Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group--a review of 45 cases. (1995) (81)
Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. (1991) (80)
Predictive factors for post-poliomyelitis syndrome. (1994) (80)
The needs of patients with arthritis: the patient's perspective. (1999) (80)
Diagnostic associations with hypermobility in rheumatology patients. (1995) (79)
The relationship between health status, social support and satisfaction with medical care among patients with systemic lupus erythematosus. (1999) (76)
HAIRY-CELL LEUKÆMIA WITH POLYARTHRITIS NODOSA (1979) (76)
The role of stress in functional disability among women with systemic lupus erythematosus: a prospective study. (1999) (75)
Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. (2000) (75)
Cellular immunity to the G1 domain of cartilage proteoglycan aggrecan is enhanced in patients with rheumatoid arthritis but only after removal of keratan sulfate. (1998) (75)
Quality of life in systemic lupus erythematosus patients during more and less active disease states: differential contributors to mental and physical health. (1999) (74)
Natural history of cartilage damage and osteoarthritis progression on magnetic resonance imaging in a population-based cohort with knee pain. (2011) (72)
A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis. (2003) (72)
Methotrexate in systemic lupus erythematosus (2005) (72)
Quality of Nonpharmacological Care in the Community for People with Knee and Hip Osteoarthritis (2011) (71)
Living with lupus: a prospective pan-Canadian study. (2001) (71)
The overdiagnosis of fibromyalgia syndrome. (1997) (69)
The systemic lupus erythematosus Tri-nation Study: absence of a link between health resource use and health outcome. (2004) (67)
The systemic lupus erythematosus Tri-Nation study: cumulative indirect costs. (2007) (67)
The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities. (2007) (65)
The impact of low family income on self-reported health outcomes in patients with rheumatoid arthritis within a publicly funded health-care environment. (2004) (65)
An international perspective on the well being and health care costs for patients with systemic lupus erythematosus. Tri-Nation Study Group. (1999) (65)
Association of clinical findings with pre–radiographic and radiographic knee osteoarthritis in a population‐based study (2010) (64)
Association of Smoking With Cutaneous Manifestations in Systemic Lupus Erythematosus (2013) (63)
Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. (1983) (63)
Tuberculosis of the sacroiliac joint: clinical features, outcome, and evaluation of closed needle biopsy in 11 consecutive cases. (1988) (63)
Wegener's granulomatosis. Clinical features and outcome in 13 patients. (1983) (62)
Counterbalancing patient demands with evidence: Results from a pan-canadian randomized clinical trial of brief supportive-expressive group psychotherapy for women with systemic lupus erythematosus (2002) (61)
Occupational role performance in persons with back pain. (1998) (61)
Diagnosis and treatment of ossification of the posterior longitudinal ligament of the spine: report of eight cases and literature review. (1992) (60)
Group psychotherapy reduces illness intrusiveness in systemic lupus erythematosus. (2003) (60)
The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group. (2000) (59)
Reliability of the hip examination in osteoarthritis: effect of standardization. (2008) (58)
Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. Tri-Nation Study Group. (2000) (57)
Deforming arthritis in systemic lupus erythematosus. (1981) (57)
Response to treatment as a predictor of longterm outcome in patients with lupus nephritis. (1994) (55)
When patients have to pay a share of drug costs: effects on frequency of physician visits, hospital admissions and filling of prescriptions (2005) (55)
The longterm prognosis of lupus nephritis: the impact of disease activity. (1993) (54)
A controlled study of the long-term prognosis of adult Still's disease. (1995) (53)
Autoimmunity to cartilage link protein in patients with rheumatoid arthritis and ankylosing spondylitis. (1998) (53)
Comprehensive radiographic evaluation of diffuse idiopathic skeletal hyperostosis: development and interrater reliability of a scoring system. (1998) (52)
HLA-Bw35 and prognosis in adult Still's disease. (1981) (52)
Pharmacist‐initiated intervention trial in osteoarthritis: A multidisciplinary intervention for knee osteoarthritis (2012) (52)
Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study (2011) (51)
Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers. (2005) (51)
The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being. (2005) (50)
Improving osteoarthritis detection in the community: pharmacist identification of new, diagnostically confirmed osteoarthritis. (2007) (50)
Antibiotics for Treatment of Reactive Arthritis: A Systematic Review and Metaanalysis (2013) (48)
Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis. (1999) (46)
Racial differences in social network experience and perceptions of benefit of arthritis treatments among New York City Medicare beneficiaries with self-reported hip and knee pain. (2002) (46)
The Effect of Disease Site (Knee, Hip, Hand, Foot, Lower Back or Neck) on Employment Reduction Due to Osteoarthritis (2010) (44)
Inflammatory Arthritis Prevalence and Health Services Use in the First Nations and Non–First Nations Populations of Alberta, Canada (2017) (44)
Best Practices for Cardiovascular Disease Prevention in Rheumatoid Arthritis: A Systematic Review of Guideline Recommendations and Quality Indicators (2015) (44)
Hepatic abnormalities in adult onset Still's disease. (1979) (44)
Femoroacetabular impingement and osteoarthritis of the hip. (2015) (43)
Survey of antimalarial use in lupus pregnancy and lactation. (2002) (43)
Do spouses know how much fatigue, pain, and physical limitation their partners with rheumatoid arthritis experience? Implications for social support (2011) (43)
Treatment of Wegener's granulomatosis after renal transplantation: is cyclosporine the preferred treatment? (1990) (43)
Pelvic Bone Asymmetry in 323 Study Participants Receiving Abdominal CT Scans (2003) (42)
Incidence, prevalence, and evidence. Scientific problems in epidemiologic statistics for the occurrence of cancer. (1987) (41)
Assessment of health-related quality of life in arthritis: conceptualization and development of five item banks using item response theory (2006) (41)
Development of Cardiovascular Quality Indicators for Rheumatoid Arthritis: Results from an International Expert Panel Using a Novel Online Process (2015) (41)
Risk factors for adult Still's disease. (1996) (40)
Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis. (1999) (40)
A proof-of-concept study of the "Employment and Arthritis: Making It Work" program. (2008) (39)
The relationship of socioeconomic status to subsequent health status in systemic lupus erythematosus. (1988) (39)
Diagnostic Accuracy of Technologies Used in Low Back Pain Assessment: Thermography, Triaxial Dynamometry, Spinoscopy, and Clinical Examination (1996) (39)
Vascular involvement in relapsing polychondritis. (1977) (39)
Nonphysician practitioner treatments and fibromyalgia syndrome. (1997) (38)
After patients are diagnosed with knee osteoarthritis, what do they do? (2010) (36)
An Overview of Economic Evaluations for Drugs Used in Rheumatoid Arthritis (2012) (36)
Hydroxychloroquine prescription trends and predictors for excess dosing per recent ophthalmology guidelines (2018) (35)
A reappraisal of the United Kingdom epidemic of fatal asthma. Can general mortality data implicate a therapeutic agent? (1987) (34)
Patient education and self-management of musculoskeletal diseases. (2008) (34)
Predictive value of radionuclide joint scintigrams. (1982) (32)
Why health care costs more in the US: comparing health care expenditures between systemic lupus erythematosus patients in Stanford and Montreal. (1996) (32)
Joint imaging in regional migratory osteoporosis. (1980) (32)
Can Experienced Clinicians Predict the Outcome of Lupus Nephritis? (1992) (31)
Musculoskeletal complaints and fibromyalgia in patients attending a respiratory sleep disorders clinic. (1996) (30)
Acceptability of an online modified Delphi panel approach for developing health services performance measures: results from 3 panels on arthritis research (2017) (30)
The association of magnetic resonance imaging (MRI)-detected structural pathology of the knee with crepitus in a population-based cohort with knee pain: the MoDEKO study. (2010) (30)
Carpal alterations in adult-onset Still disease, juvenile chronic arthritis, and adult-onset rheumatoid arthritis: comparative study. (1987) (29)
Prospective evaluation of sacroiliac scintigraphy in chronic inflammatory back pain. (1980) (29)
Frequency of Bone Marrow Lesions and Association with Pain Severity: Results from a Population-based Symptomatic Knee Cohort (2011) (29)
Observational studies of cause-effect relationships: an analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of rheumatoid arthritis. (1986) (28)
An immunogenetic study of older age onset rheumatoid arthritis. (1984) (28)
The impact of disease activity, treatment and disease severity on short-term costs of systemic lupus erythematosus. (1994) (28)
A Case-Control Analysis of Nonsteroidal Anti-Inflammatory Drugs and Alzheimer’s Disease: Are They Protective? (2002) (28)
Reliability of Hip Examination Tests for Femoroacetabular Impingement (2013) (27)
Associations between MRI features versus knee pain severity and progression: Data from the Vancouver Longitudinal Study of Early Knee Osteoarthritis (2017) (27)
Prevalence of Co-existing Autoimmune Disease in Rheumatoid Arthritis: A Cross-Sectional Study (2017) (27)
The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry. (2001) (27)
Decreasing costs and improving outcomes in systemic lupus erythematosus: using regression trees to develop health policy. (1994) (26)
Exercise therapy for patients with diffuse idiopathic skeletal hyperostosis (2008) (25)
Imbalance of Prevalence and Specialty Care for Osteoarthritis for First Nations People in Alberta, Canada (2015) (24)
The prevalence of radiographic femoroacetabular impingement in younger individuals undergoing total hip replacement for osteoarthritis (2012) (24)
Chest radiographs as a screening test for diffuse idiopathic skeletal hyperostosis. (1993) (24)
All‐Cause and Cause‐Specific Mortality in Patients With Granulomatosis With Polyangiitis: A Population‐Based Study (2018) (23)
Alpha-1 antitrypsin deficiency and systemic necrotizing vasculitis. (1991) (23)
Risk of Incident Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population‐Based Cohort Study (2019) (23)
The Effect of Cash Lottery on Response Rates to an Online Health Survey among Members of the Canadian Association of Retired Persons: A Randomized Experiment (2010) (23)
Radionuclide joint imaging. (1983) (23)
Cost‐Utility Analysis of a Multidisciplinary Strategy to Manage Osteoarthritis of the Knee: Economic Evaluation of a Cluster Randomized Controlled Trial Study (2014) (23)
Influence of lifetime hip joint force on the risk of self-reported hip osteoarthritis: a community-based cohort study. (2011) (22)
Ankylosing spondylitis antirheumatic drug trials. I. Effects of standardization procedures on observer dependent outcome measures. (1991) (22)
Health economic evaluation: a primer for the practicing rheumatologist. (2006) (22)
The risk and trend of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a general population-based study. (2020) (22)
Idiopathic fibrosis of the lateral compartment of the neck. (1980) (22)
Generalized skeletal response to 99mtechnetium methylene diphosphonate in rheumatoid arthritis. (1982) (22)
Ectopic production of 1,25-dihydroxyvitamin D3 in tuberculosis. (1993) (21)
Sudden quadriplegia complicating ossification of the posterior longitudinal ligament and diffuse idiopathic skeletal hyperostosis. (1987) (21)
Hydroxychloroquine and Mortality Among Patients With Systemic Lupus Erythematosus in the General Population (2020) (21)
Gaps in Addressing Cardiovascular Risk in Rheumatoid Arthritis: Assessing Performance Using Cardiovascular Quality Indicators (2016) (20)
Development and Validation of a Novel Evidence‐Based Lupus Multivariable Outcome Score for Clinical Trials (2018) (20)
The relationship between subchondral sclerosis detected with MRI and cartilage loss in a cohort of subjects with knee pain: the knee osteoarthritis progression (KOAP) study. (2014) (20)
The validity of a non-radiologist reader in identifying cam and pincer femoroacetabular impingement (FAI) using plain radiography (2014) (19)
“Employment and arthritis: making it work” a randomized controlled trial evaluating an online program to help people with inflammatory arthritis maintain employment (study protocol) (2014) (19)
Longitudinal Evolution of Risk of Coronary Heart Disease in Systemic Lupus Erythematosus (2012) (18)
Aspects of use of antimalarials in systemic lupus erythematosus. (1998) (17)
The incidence of depression and anxiety in patients with ankylosing spondylitis: a systematic review and meta-analysis (2019) (17)
Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study (2019) (17)
Hairy-cell leukaemia with polyarteritis nodosa. (1979) (16)
Depressive Symptoms and Rheumatoid Arthritis: Spouse Empathic Responding as a Buffer (2014) (16)
Lifetime trajectory of physical activity according to energy expenditure and joint force (2010) (16)
Systemic lupus erythematosus activity. An operational definition. (1988) (16)
Relationship between physical activity and hip pain in persons with and without cam or pincer morphology: a population-based case-control study. (2017) (16)
Trends of venous thromboembolism risk before and after diagnosis of gout: a general population-based study. (2019) (15)
Current role of renal biopsy in patients with SLE. (1998) (15)
Association of body mass index with knee cartilage damage in an asymptomatic population-based study (2017) (14)
Association of anti-DNA idiotype markers with clinical and serological manifestations in patients with systemic lupus erythematosus. (1990) (14)
Atypical presentations of polymyalgia rheumatica. (1990) (14)
Prognosis in systemic lupus erythematosus (2004) (14)
HLA B27 in rheumatoid factor-negative polyarthritis. (1977) (14)
Quadriceps Weakness and Risk of Knee Cartilage Loss Seen on Magnetic Resonance Imaging in a Population-based Cohort with Knee Pain (2018) (14)
A double blind multicenter trial comparing piroxicam and indomethacin in ankylosing spondylitis with long-term follow-up (1984) (14)
Quality of care for cardiovascular disease prevention in rheumatoid arthritis: compliance with hyperlipidemia screening guidelines (2018) (13)
Rheumatology: 3. Getting the most out of radiology. (2000) (13)
Rheumatology: introduction to the series (2000) (12)
Mathematical models and scientific reality in occurrence rates for disease. (1989) (12)
The benefit of early treatment with immunosuppressive drugs in lupus nephritis. (1995) (12)
Association of Body Mass Index With Incidence and Progression of Knee Effusion on Magnetic Resonance Imaging and on Knee Examination (2016) (12)
Double-blind comparison of tolmetin sodium and indomethacin in ankylosing spondylitis. (1982) (12)
A conceptual framework for clinical trials in SLE and other multisystem diseases (1999) (12)
The cost of COX inhibitors: how selective should we be? (2000) (12)
Elevated uptake of 99mtechnetium methylene diphosphonate in the axial skeleton in ankylosing spondylitis and Reiter's disease: implications for quantitative sacroiliac scintigraphy. (1983) (11)
Antimalarial Medications (2019) (11)
Thrombosis in systemic lupus erythematosus: the role of antiphospholipid antibody. (1999) (11)
Inpatient rheumatic disease units: are they worth it? (1993) (11)
Absence of an association of rheumatoid arthritis and diffuse idiopathic skeletal hyperostosis: a case-control study. (1995) (11)
Reticuloendothelial system Fc receptor function in systemic lupus erythematosus. (1982) (11)
Ankylosing spondylitis antirheumatic drug trials. III. Setting the delta for clinical trials of antirheumatic drugs--results of a consensus development (Delphi) exercise. (1991) (11)
Adult Prevalence Of Systemic Autoimmune Rheumatic Diseases (SARDs) In British Columbia, Canada (2011) (10)
Reticuloendothelial system Fc receptor function in systemic lupus erythematosus: effect of decreased sensitization on clearance of autologous erythrocytes. (1987) (10)
[Lupus. The disease with a thousand faces]. (1991) (10)
Vasculitis as a presenting manifestation of primary biliary cirrhosis: a case report. (1984) (10)
Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy with cyclosporine. Canadian Multicentre Rheumatology Group. (1994) (10)
Approval process and access to prescription drugs in Canada. (2006) (9)
Radionuclide joint imaging in the seronegative spondyloarthropathies. (1979) (9)
Prevalence of Femoroacetabular Impingement Syndrome among Young and Middle-aged White Adults (2019) (9)
Ankylosing spondylitis antirheumatic drug trials. II. Tables for calculating sample size for clinical trials. (1991) (9)
Intravenous immunoglobulin (IVIG) for orbital Wegener's granulomatosis. (2012) (9)
Effectiveness of an online self-management tool, OPERAS (an On-demand Program to EmpoweR Active Self-management), for people with rheumatoid arthritis: a research protocol (2019) (9)
Response to initial therapy and new onset as predictors of prognosis in patients hospitalized with congestive heart failure. (1992) (8)
Capitalizing on the Teachable Moment: Osteoarthritis Physical Activity and Exercise Net for Improving Physical Activity in Early Knee Osteoarthritis (2013) (8)
Rheumatologists’ Views and Perceived Barriers to Using Patient Decision Aids in Clinical Practice (2015) (8)
Incidence, Prevalence, and Evidence. Scientific Problems in Epidemiologic Statistics for the Occurrence of Cancer (1987) (8)
How to manage patients with lupus nephritis. (2002) (8)
Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis (2021) (8)
Cardiovascular Disease Prevention in Rheumatoid Arthritis: Compliance with Diabetes Screening Guidelines (2018) (8)
Association of Femoroacetabular Impingement and Delayed Gadolinium‐Enhanced Magnetic Resonance Imaging of Cartilage: A Population‐Based Study (2018) (7)
A double-blind multicenter, controlled study on diclofenac (Voltaren®) and naproxen in patients with rheumatoid arthritis (R.A.) (1984) (7)
Modeling percentage change: a potential linear mirage. (1989) (7)
Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study. (2021) (7)
Adherence to Antimalarial Therapy and Risk of Type 2 Diabetes Mellitus Among Patients With Systemic Lupus Erythematosus: A Population‐Based Study (2020) (7)
QUALITY OF LIFE IN SLE DURING ACTIVE AND INACTIVE DISEASE STATES: DIFFERENTIAL CONTRIBUTORS TO MENTAL AND PHYSICAL HEALTH (1999) (7)
Specific manifestations of knee osteoarthritis predict depression and anxiety years in the future: Vancouver Longitudinal Study of Early Knee Osteoarthritis (2020) (6)
Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study (2022) (6)
Asthma mortality. How high is up? And is it up? (1987) (6)
Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: A population-based study. (2021) (6)
Multifocal idiopathic fibrosclerosis: treatment of 2 cases with cyclosporine. (2006) (6)
Chapter 49 – Antimalarial Medications (2013) (6)
Utility of Electronic Medical Records in Community Rheumatology Practice for Assessing Quality of Care Indicators for Gout: A Feasibility Study (2017) (6)
Impact of Systemic Lupus Erythematosus on the Risk of Newly Diagnosed Hip Fracture: A General Population‐Based Study (2019) (5)
Exogenous female hormones and rheumatoid arthritis: a methodological view of the contradictions in the literature. (1989) (5)
Development of a paper-and-pencil semi-adaptive questionnaire for 5 domains of health-related quality of life (PAT-5D-QOL) (2013) (5)
Mortality trends in polymyositis and dermatomyositis: A general population-based study. (2020) (5)
Risk of Gastrointestinal Events in Patients with Rheumatoid Arthritis After Withdrawal of Rofecoxib (2012) (5)
Design of a Randomized Trial of a Multidisciplinary Intervention for Knee Osteoarthritis: Pharmacist Initiated Intervention Trial in Osteoarthritis (PhIT-OA): (2008) (5)
Rheumatoid Arthritis: Plan to Win (2002) (5)
Impact of Antimalarial Adherence on Mortality Among Patients With Newly Diagnosed Systemic Lupus Erythematosus: A Population‐Based Cohort Study (2021) (5)
Reliability of hip examination tests for femoroacetabular impingement (FAI) (2012) (4)
Multiattribute health utility scoring for the computerized adaptive measure CAT-5D-QOL was developed and validated. (2015) (4)
Carpal tunnel syndrome complicated by reflex sympathetic dystrophy syndrome. (1991) (4)
Descriptive epidemiology of musculoskeletal disorders in Canada: data from the global burden of disease study (2019) (4)
First lifetime back pain and psychiatry treatment: psychological factors and recovery in compensated workers. (2000) (4)
First Lifetime Back Pain and Physiatry Treatment (2000) (3)
The Efficacy of Antimalarials in Systemic Lupus Erythematosus (1993) (3)
The prevalence and diagnostic accuracy of clinical exam tests in identifying radiographic femoroacetabular impingement (FAI): A prospective population-based study (2015) (3)
Relationship Between Hip Morphology and Hip‐Related Patient‐Reported Outcomes in Young and Middle‐Aged Individuals: A Population‐Based Study (2019) (3)
Agreement among Ayurvedic practitioners in the identification and treatment of three cases of inflammatory arthritis. (2003) (3)
Responsiveness of Health State Utility Values in Knee Osteoarthritis (2013) (3)
A whole-joint, unidimensional, irreversible, and fine-grained MRI knee osteoarthritis severity score, based on cartilage, osteophytes and meniscus (OA-COM) (2021) (3)
Significant association of radiographic femoroacetabular impingement with early MRI features of hip disease: A population-based study (2016) (2)
Systemic lupus erythematosus--disease activity, severity, treatment, and costs. (1995) (2)
P224 IDENTIFICATION OF EARLY KNEE OSTEOARTHRITIS: RESULTS FROM THE DEVELOPMENT OF A MODEL FOR THE DIAGNOSIS OF EARLY KNEE OSTEOARTHRITIS (MODEKO) STUDY (2006) (2)
Defining Depression and Anxiety in Individuals With Rheumatic Diseases Using Administrative Health Databases: A Systematic Review (2020) (2)
System-level performance measures of access to rheumatology care: a population-based retrospective study of trends over time and the impact of regional rheumatologist supply in Ontario, Canada, 2002–2019 (2022) (2)
More thoughts about antimalarials: should one prescribe chloroquine? (1999) (2)
Reappraisal of the United Kingdom Epidemic of Fatal Asthma-Reply (1987) (2)
116 SERUM BIOMARKER STUDIES OF SYMPTOMATIC SUBJECTS WITH PERSISTENT KNEE PAIN WITH AND WITHOUT OA REVEAL SIGNIFICANT DIFFERENCES FROM ASYMPTOMATIC SUBJECTS IN SYSTEMIC MARKERS OF INFLAMMATION SUGGESTING DIFFERENCES IN INNATE IMMUNITY (2010) (2)
CHAPTER 5C – Comorbidity in Rheumatoid Arthritis (2009) (2)
Does moderate or severe nonspecific knee injury affect radiographic osteoarthritis incidence and progression? (2013) (2)
A Population‐Based Study Evaluating Retention in Rheumatology Care Among Patients With Rheumatoid Arthritis (2022) (2)
OP0010 EFFECTIVENESS OF THE MAKING IT WORK™ PROGRAM AT IMPROVING PRESENTEEISM AND WORK CESSATION IN WORKERS WITH INFLAMMATORY ARTHRITIS – RESULTS OF A RANDOMIZED CONTROLLED TRIAL (2020) (2)
Open-label tolerability study of enteric-coated naproxen in the treatment of osteoarthritis and rheumatoid arthritis. (1992) (1)
THU0440 Temporal trends of venous thromboembolism risk before and after diagnosis of gout. a general population-based study (2017) (1)
Letter to the editorResponse (1987) (1)
THU0219 Prevalence of Joint Pain and Self-Reported Osteoarthritis in British Columbia, Canada (2014) (1)
Commentary on article by S. R. Daniels et al. (1995) (1)
OP0191 ASSOCIATION OF TRAMADOL WITH ALL-CAUSE MORTALITY, CARDIOVASCULAR DISEASE, VENOUS THROMBOEMBOLISM AND HIP FRACTURES AMONG PATIENTS WITH OSTEOARTHRITIS. A POPULATION-BASED STUDY (2020) (1)
Design of a Randomized Trial of a Multidisciplinary Intervention for Knee Osteoarthritis: Pharmacist Initiated Intervention Trial in Osteoarthritis (PhIT-OA) (2008) (1)
A comparison of three strategies to reduce the burden of osteoarthritis: A population-based microsimulation study (2021) (1)
Association of Knee Effusion Detected by Physical Examination With Bone Marrow Lesions: Cross‐Sectional and Longitudinal Analyses of a Population‐Based Cohort (2019) (1)
299 Increased mortality among patients with systemic lupus erythematosus after hydroxychloroquine discontinuation (2019) (1)
PMS44 VALIDATION OF THE MULTI-ATTRIBUTE HEALTH UTILITY (MAHU) DERIVED FROM A COMPUTER ADAPTIVE INSTRUMENT, CAT-5D-QOL, IN OSTEOARTHRITIS (2009) (1)
Reliability and standardization of the hip examination in osteoarthritis (2008) (1)
The association of MRI-detected subchondral bone marrow sclerosis with cartilage loss in a cohort of subjects with knee pain (2012) (1)
DOES ANTIMALARIAL ADHERENCE DECREASE THE RISK OF CARDIOVASCULAR EVENTS AND MORTALITY AMONG PATIENTS WITH INCIDENT SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS? A POPULATION-BASED STUDY (2022) (0)
113 ANALYSIS OF 31 BIOMARKERS AND BIOMARKER FACTORS IN PRE-RADIOGRAPHIC AND RADIOGRAPHIC KNEE OSTEOARTHRITIS: RESULTS OF A POPULATION-BASED STUDY USING MRI (2009) (0)
Predicting OA progression: results from the Vancouver knee osteoarthritis progression study (2012) (0)
List of Contributors (2019) (0)
FRI0371 Autoimmune Diseases in Patients with Rheumatoid Arthritis (2015) (0)
Magnetic resonance imaging predictors (cartilage, osteophytes and meniscus) of prevalent and 3-year incident medial and lateral tibiofemoral knee joint tenderness and patellofemoral grind (2022) (0)
FRI0207 Prevalence of Femoroacetabular Impingement in Caucasians Compared to Chinese in Vancouver, Canada: A Population-Based Study (2014) (0)
Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population‐Based Study (2023) (0)
Is maintenance in gold therapy necessary? A double-blind, placebo controlled, gold discontinuation study (2000) (0)
BD-03 Adherence to antimalarials and risk of type 2 diabetes mellitus in patients with systemic lupus erythematosus: a population-based cohort study (2018) (0)
59 ADAPTIVE ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE IN PERSONS WITH HIP AND KNEE PAIN (2007) (0)
352 COMPARISON OF LIFETIME ENERGY EXPENDITURE AND KNEE AND HIP JOINT FORCE: DIFFERENT WAYS TO QUANTIFY PHYSICAL ACTIVITY (2008) (0)
76 Risk of hip fracture among patients with newly diagnosis of systemic lupus erythematosus. A population-based study (2019) (0)
Proceedings of the Second Update on Psoriatic Disease, University Federico II Congress Center, July 6–7, 2011, Naples, Italy. (2012) (0)
Steroid interactions affecting metabolic activities of a T-lymphocyte line. (1992) (0)
302 COMPARING MAGNETIC RESONANCE IMAGING-BASED DEFINITIONS OF KNEE OSTEOARTHRITIS TO X-RAY-BASED KELLGREN-LAWRENCE GRADE FOR PREDICTING DISEASE SEVERITY (2009) (0)
Research methods in epidemiology , V Bias in case-control studies . A review (0)
323 DO PHYSICAL EXAMINATIONS PREDICT OA PROGRESSION BASED ON MRI? RESULTS FROM THE VANCOUVER KNEE OSTEOARTHRITIS PROGRESSION STUDY (2011) (0)
MODELING PERCENTAGE CHANGE: A POTENTIAL (1989) (0)
THU0128 Characteristics of Patients with Rheumatoid Arthritis in Kuwait: Results from the Krrd Registry (2015) (0)
Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis (2023) (0)
Reducing the burden of low back pain: results from a new microsimulation model (2022) (0)
Brief Supportive-Expressive PsychotherapyIn A Systemic LupusErythematosus (Sle): ChangingThemes And Psychological Distress (2003) (0)
SAT0424 Trends in Osteoarthritis Incidence in British Columbia, Canada, 2001-2012 (2016) (0)
340 THE INFLUENCE OF LIFETIME HIP JOINT FORCE ON THE RISK OF SELF-REPORTED HIP OSTEOARTHRITIS: A NEW METHOD TO QUANTIFY PHYSICAL ACTIVITY (2008) (0)
RetINal Toxicity And HydroxyChloroquine Therapy (INTACT): protocol for a prospective population-based cohort study (2022) (0)
Correction: Association of tramadol with all-cause mortality, cardiovascular diseases, venous thromboembolism, and hip fractures among patients with osteoarthritis: a population-based study (2022) (0)
Associations between knee pain severity and progression versus MRI features: The vancouver longitudinal study of early knee OA (2015) (0)
Rheumatoid Arthritis Linked to an Increased Risk of COPD (2017) (0)
PAR7: THE LONGTERM SAFETY AND EFFECTIVENESS OF CYCLOSPORINE IN PATIENTS WITH SEVERE RHEUMATOID ARTHRITIS (RA) (2000) (0)
OP0051 Relationship Between Physical Activity and Hip Pain in Persons with and Without Femoroacetabular Impingement: A Population-Based Case-Control Study (2015) (0)
345 IMPACT OF TOTAL PHYSICAL ACTIVITY IN YOUNGER AGE ON PHYSICAL AND MENTAL HEALTH IN PEOPLE WITH OSTEOARTHRITIS OF THE KNEE (2009) (0)
Elevated risk of chronic obstructive pulmonary disease in systemic lupus erythematosus: a population-based study (2014) (0)
A new sandwich biomarker assay for cartilage type ii collagen can discriminate between no osteoarthritis (oa), pre-radiographic and radiographic knee oa in human urine (2012) (0)
THU0615 Participants' experience of the making it work program, an online program to help people with inflammatory arthritis remain employed (2017) (0)
CLINICAL EFFECTIVENESS OF OUTPATIENT PHYSIOTHERAPY VS EXERCISES ALONE POST THA: A PROSPECTIVE RCT (2008) (0)
Human Health and Disease (1977) (0)
Getting the most out of radiology (2000) (0)
Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis. (2023) (0)
Delayed Gadolinium‐Enhanced Magnetic Resonance Imaging of Cartilage Values in Hips With Bone Marrow Lesions (2021) (0)
Running title: Association of femoroacetabular impingement with dGEMRIC THE ASSOCIATION OF FEMOROACETABULAR IMPINGEMENT AND DELAYED GADOLINIUM ENHANCED MRI OF CARTILAGE (DGEMRIC): A POPULATION-BASED STUDY (2017) (0)
COMMENT ON: LABORATORY TESTS AS PREDICTORS OF DISEASE EXACERBATION IN SYSTEMIC LUPUS ERYTHEMATOSUS (1996) (0)
Simplified clinical prediction model for osteoarthritis progression based on MRI: results from the Vancouver knee osteoarthritis progression (KOAP) study (2013) (0)
The randomized clinical trial in orthopaedics: obligation or option? (1985) (0)
The association of femoral acetabular impingement and delayed gadolinium enhanced MRI of cartilage (DGEMRIC): A population-based study (2016) (0)
POS0303 PREVENTION OF CHRONIC DISEASES DUE TO INFLAMMATION IN INFLAMMATORY ARTHRITIS: RESULTS OF A DELPHI PROCESS TO SELECT CARE RECOMMENDATIONS FOR AN ELECTRONIC MEDICAL RECORD (EMR) INTERVENTION (2021) (0)
304 QUANTIFYING DECLINE IN QUALITY OF LIFE DUE TO DISEASE DURATION IN PERSONS WITH PRE-EXISTING KNEE OR HIP OSTEOARTHRITIS (2008) (0)
Deforming arthritis insystemic lupus erythematosus (1981) (0)
289 THE EFFECT OF PHYSICIAN ASSESSED QUADRICEPS MUSCLE STRENGTH ON SUBSEQUENT PROGRESSION OF KNEE OSTEOARTHRITIS (OA) (2010) (0)
Severe COVID-19 outcomes among patients with autoimmune rheumatic diseases or transplantation: a population-based matched cohort study (2022) (0)
SUPPORTIVE-EXPRESSIVE PSYCHOTHERAPY IN A SYSTEMIC LUPUS ERYTHEMATOSUS ( SLE ) : CHANGING THEMES AND PSYCHOLOGICAL DISTRESS (2015) (0)
The Impact of 51 Risk Factors on Life Expectancy in Canada: Findings from a New Risk Prediction Model Based on Data from the Global Burden of Disease Study (2022) (0)
nomenclature of a and r 1983 (2015) (0)
SAT0175 IMPACT OF ANTIMALARIAL ADHERENCE ON MORTALITY AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A POPULATION-BASED COHORT STUDY (2020) (0)
Evaluation clinique expérimentale de la validité d'instruments utilisés pour le diagnostic des lombalgies : Spinoscopie, dynamométrie triaxiale (B-200) et thermographie, en regard de l'examen clinique (1997) (0)
Risk of Arrhythmia among New Users of Hydroxychloroquine in RA and SLE: A Population-based Study. (2022) (0)
A serine/threonine phosphatase, PP2A, controls autoimmunity (2014) (0)
SAT0605 TRENDS OF TOTAL JOINT ARTHROPLASTY AMONG PATIENTS WITH OSTEOARTHRITIS, RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS IN BRITISH COLUMBIA, CANADA, 1998-2013 (2020) (0)
SAT0242 REGIONAL VARIATION IN CARDIOVASCULAR DISEASE AMONG SLE PATIENTS (2020) (0)
Associations of clinical and biomarker variables with cartilage damage in painful pre-radiographic knee osteoarthritis. results from a population-based study (2013) (0)
Re: "Do pressurized bronchodilator aerosols cause death among asthmatics?". (1988) (0)
CE-14 Improved survival in systemic lupus erythematosus: a population-based study (2016) (0)
Association of biomarkers with osteoarthritis progression based on MRI: results from the Vancouver knee osteoarthritis progression (KOAP) study (2013) (0)
405 Does antimalarial adherence decrease the risk of cardiovascular events and mortality among patients with incident systemic lupus erythematosus and rheumatoid arthritis? A population-based study (2021) (0)
Effectiveness of an online self-management tool for people with rheumatoid arthritis: a research protocol (2019) (0)
SURGEONS AND TRIALS (1986) (0)
Prevalence of joint-specific osteoarthritis and joint pain in British Columbia, Canada (2021) (0)
SOCIAL SUPPORT AND HEALTH STATUS INFLUENCE SATISFACTION WITH MEDICAL CARE AMONG PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (1998) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With John M. Esdaile?

John M. Esdaile is affiliated with the following schools: